The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
Open accessAbstract
Purpose: This phase III trial compared adjuvant whole-brain radiotherapy (WBRT) with observation after either surgery or radiosurgery of a limited number of brain metastases in patients with stable solid tumors. Here, we report the health-related quality-of-life (HRQOL) results. Patients and Methods: HRQOL was a secondary end point in the trial. HRQOL was assessed at baseline, at 8 weeks, and then every 3 months for 3 years with the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire C30 and Brain Cancer Module. The following six primary HRQOL scales were considered: global health status; physical, cognitive, role, and emotional functioning; and fatigue. Statistical significance required P ≤ .05, and clinical relevance required a ≥ 10-point difference. Results: Compliance was 88.3% at baseline and dropped to 45.0% at 1 year; thus, only the first year was analyzed. Overall, patients in the observation only arm reported better HRQOL scores than did patients who received WBRT. The differences were statistically significant and clinically relevant mostly during the early follow-up period (for global health status at 9 months, physical functioning at 8 weeks, cognitive functioning at 12 months, and fatigue at 8 weeks). Exploratory analysis of all other HRQOL scales suggested worse scores for the WBRT group, but none was clinically relevant. Conclusion: This study shows that adjuvant WBRT after surgery or radiosurgery of a limited number of brain metastases from solid tumors may negatively impact some aspects of HRQOL, even if these effects are transitory. Consequently, observation with close monitoring with magnetic resonance imaging (as done in the EORTC trial) is not detrimental for HRQOL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Interpreting the significance of changes in health-related quality-of-life scores.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.139 · Cited by 2,961
Gaspar, L., Scott, C., Rotman, M., Asbell, S., Phillips, T., Wasserman, T., McKenna, W. G., & Byhardt, R. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,544
Chang, E. L., Wefel, J. S., Hess, K. R., Allen, P. K., Lang, F. F., Kornguth, D. G., Arbuckle, R. B., Swint, J. M., Shiu, A. S., Maor, M. H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70263-3 · Cited by 2,475
Aoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2483 · Cited by 2,213
Kocher, M., Soffietti, R., Abacioglu, U., Villà, S., Fauchon, F., Baumert, B. G., Fariselli, L., Tzuk-Shina, T., Kortmann, R.-D., Carrie, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1655 · Cited by 1,988
Self-citationPostoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. (1998) · JAMA · doi:10.1001/jama.280.17.1485 · Cited by 1,915
Quality of life measurement: bibliographic study of patient assessed health outcome measures
Garratt, A., Schmidt, L., Mackintosh, A., & Fitzpatrick, R. (2002) · BMJ · doi:10.1136/bmj.324.7351.1417 · Cited by 1,192
Sperduto, P. W., Berkey, B., Gaspar, L. E., Mehta, M., & Curran, W. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Aoyama, H., Tago, M., Kato, N., Toyoda, T., Kenjyo, M., Hirota, S., Shioura, H., Inomata, T., Kunieda, E., Hayakawa, K., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.048 · Cited by 545
Design and Analysis of Quality of Life Studies in Clinical Trials
Fairclough, D. L. (2002) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420035438 · Cited by 461
Taphoorn, M. J. B., Claassens, L., Aaronson, N. K., Coens, C., Mauer, M., Osoba, D., Stupp, R., Mirimanoff, R. O., van den Bent, M. J., & Bottomley, A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.01.012 · Cited by 391
Self-citationSun, A., Bae, K., Gore, E. M., Movsas, B., Wong, S. J., Meyers, C. A., Bonner, J. A., Schild, S. E., Gaspar, L. E., Bogart, J. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.6053 · Cited by 369
Osoba, D., Aaronson, N. K., Muller, M., Sneeuw, K., Hsu, M. A., Yung, W. K. A., Brada, M., & Newlands, E. (1996) · Quality of Life Research · doi:10.1007/bf00435979 · Cited by 343
Health-related quality of life in patients with glioblastoma: a randomised controlled trial
Taphoorn, M. J., Stupp, R., Coens, C., Osoba, D., Kortmann, R., van den Bent, M. J., Mason, W., Mirimanoff, R. O., Baumert, B. G., Eisenhauer, E., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70432-0 · Cited by 331
Self-citationLi, J., Bentzen, S. M., Li, J., Renschler, M., & Mehta, M. P. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.09.059 · Cited by 287
Slotman, B. J., Mauer, M. E., Bottomley, A., Faivre-Finn, C., Kramer, G. W. P. M., Rankin, E. M., Snee, M., Hatton, M., Postmus, P. E., Collette, L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0746 · Cited by 254
Self-citationEfficace, F., Bottomley, A., Osoba, D., Gotay, C., Flechtner, H., D’haese, S., & Zurlo, A. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.121 · Cited by 246
Self-citationRegine, W. F., Scott, C., Murray, K., et al. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01676-5 · Cited by 209
Review on Quality of Life Issues in Patients with Primary Brain Tumors
Taphoorn, M. J. B., Sizoo, E. M., & Bottomley, A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0291 · Cited by 189
Self-citationHealth related quality of life outcomes in cancer clinical trials
Bottomley, A., Flechtner, H., Efficace, F., Vanvoorden, V., Coens, C., Therasse, P., Velikova, G., Blazeby, J., & Greimel, E. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.05.007 · Cited by 165
Self-citationBrain metastases: current management and new developments
Soffietti, R., Rudà, R., & Trevisan, E. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32831186fe · Cited by 154
Self-citationJoly, F., Vardy, J. L., Pintilie, M., & Tannock, I. F. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm121 · Cited by 126
Lee, D. H., Han, J., Kim, H. T., Yoon, S. J., Pyo, H. R., Cho, K. H., Shin, S., Yoo, H., Lee, S. H., & Lee, J. S. (2008) · Cancer · doi:10.1002/cncr.23526 · Cited by 101
Scott, C., Suh, J. H., Stea, B., Nabid, A., & Hackman, J. (2007) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3180653c0d · Cited by 75
Guidelines for assessing quality of life in EORTC clinical trials
Young, T., de Haes, J. C. J. M., Curran, D., Fayers, P. M., & Brandberg, Y. (1999) · Cited by 73
Design and analysis of quality of life studies in clinical trials : interdisciplinary statistics
Fairclough, D. L. (2002) · Chapman & Hall/CRC eBooks · Cited by 58
The Dandelion Effect: Treat the Whole Lawn or Weed Selectively?
Mehta, M. P. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3294 · Cited by 30
Cited by
Brown, P. D., Jaeckle, K., Ballman, K. V., Farace, E., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Barker, F. G., Deming, R., Burri, S. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.9839 · Cited by 1,671
Gondi, V., Pugh, S. L., Tome, W. A., Caine, C., Corn, B., Kanner, A., Rowley, H., Kundapur, V., DeNittis, A., Greenspoon, J. N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.2909 · Cited by 1,148
Cagney, D. N., Martin, A. M., Catalano, P. J., Redig, A. J., Lin, N. U., Lee, E. Q., Wen, P. Y., Dunn, I. F., Bi, W. L., Weiss, S. E., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox077 · Cited by 825
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Nabors, L. B., Portnow, J., Ahluwalia, M., Baehring, J., Brem, H., Brem, S., Butowski, N., Campian, J. L., Clark, S. W., Fabiano, A. J., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0052 · Cited by 539
Soffietti, R., Abacioglu, U., Baumert, B., Combs, S. E., Kinhult, S., Kros, J. M., Marosi, C., Metellus, P., Radbruch, A., Villa Freixa, S. S., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now241 · Cited by 496
Self-citation
Metadata
- Authors
- Soffietti, R., Kocher, M., Abacioglu, U. M., Villa, S., Fauchon, F., Baumert, B. G., Fariselli, L., Tzuk-Shina, T., Kortmann, R.-D., Carrie, C., Ben Hassel, M., Kouri, M., Valeinis, E., van den Berge, D., Mueller, R.-P., Tridello, G., Collette, L., & Bottomley, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-01-01
- Volume
- 31
- Issue
- 1
- Pages
- 65-72
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2098677385
- Cited by
- 636
- References
- 28
- FWCI
- 32.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.